Investment
Features
FeesSafety
Academy
More
Pluang+

Genel Energy rejects £202M cash bid from DNO, which offers 38% premium and remains open to talks.

Market News
07 Aug 2026
Proactive Investors
View Source
Neutral
pluang ai news

Genel Energy has turned down a £202 million cash offer from Norwegian rival DNO, which proposed 69p per share, a 38% premium over Genel's recent price. DNO made the bid public after rejection, increasing pressure on Genel's board to negotiate. The offer includes a cash-and-shares alternative funded by existing share authorities, aiming to create a larger oil producer in the Kurdistan region of Iraq. DNO argues the deal offers value certainty amid Genel's ongoing bid for Capricorn Energy and highlights liquidity benefits for Genel investors. Further approaches from DNO remain possible under UK takeover rules.

More News

Valeo to redeem €750M bonds early on August 24, 2026, under make-whole redemption option.

Valeo to redeem €750M bonds early on August 24, 2026, under make-whole redemption option.

Valeo SE has announced it will exercise its option to redeem €750 million of its 5.375% bonds maturing in May 2027 early, with the redemption date set for August 24, 2026. This make-whole redemption means bondholders will receive a calculated amount ...

Company Fundamentals
Neutral
1 hour ago
Valeo to redeem €750M sustainability-linked bonds early on August 24, 2026

Valeo to redeem €750M sustainability-linked bonds early on August 24, 2026

Valeo SE announced it will exercise its make-whole redemption option to redeem in full its €750 million 5.375% sustainability-linked bonds due May 2027. The redemption will occur on August 24, 2026, ahead of the original maturity date, with the redem...

Company Fundamentals
Neutral
1 hour ago
Nxera Pharma reports Q2 2026 profit on milestone payments and advances in drug development.

Nxera Pharma reports Q2 2026 profit on milestone payments and advances in drug development.

Nxera Pharma announced a net profit of JPY 1,591 million (US$10.1 million) for Q2 2026, reversing a prior loss due to multiple milestone payments from partners like Neurocrine, AbbVie, and Lilly. The company progressed regulatory approvals and commer...

Company Fundamentals
Bullish
1 hour ago
Bekaert repurchases 50,500 shares and updates on liquidity agreement for early August 2026.

Bekaert repurchases 50,500 shares and updates on liquidity agreement for early August 2026.

Between July 30 and August 5, 2026, Bekaert repurchased 50,500 of its own shares worth nearly €2 million as part of its ongoing €75 million buyback program, with all repurchased shares planned for cancellation. Additionally, under its liquidity agree...

Company Fundamentals
Neutral
1 hour ago
Bekaert repurchases 50,500 shares and updates on liquidity agreement for early August 2026

Bekaert repurchases 50,500 shares and updates on liquidity agreement for early August 2026

Between July 30 and August 5, 2026, Bekaert repurchased 50,500 shares as part of its €75 million share buyback program, aiming to cancel all repurchased shares. The average price paid was €39.40 per share, totaling nearly €2 million. Additionally, un...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App